Active, not recruitingPhase 2NCT05092776
Efficacy and Safety of RPH-104 for Resolution and Prevention of Recurring Attacks in Adult Subjects With Familial Mediterranean Fever With Resistance to or Intolerance of Colchicine
Studying Familial Mediterranean fever
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- R-Pharm International, LLC
- Principal Investigator
- Mikhail SamsonovR-Pharm
- Intervention
- RPH-104(biological)
- Enrollment
- 84 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2021 – 2025
Study locations (14)
- Center of Medical Genetics and Primary Health Care, Yerevan, Armenia
- Mikaelyan Institute Of Surgery CJSC, Yerevan, Armenia
- Inova LLC, Tbilisi, Georgia
- The First Medical Center Ltd., Tbilisi, Georgia
- Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russia
- Multidisciplinary Scientific and Clinical Center named after S.P. Botkin, Moscow, Russia
- Medical Technologies Ltd, Saint Petersburg, Russia
- Saint-Petersburg Pasteur Institute, Saint Petersburg, Russia
- Terafarm, Llc, Stavropol, Russia
- Hacettepe University Faculty of Medicine, Ankara, Turkey (Türkiye)
- Gazi University Faculty of Medicine, Ankara, Turkey (Türkiye)
- Akdeniz University Faculty of Medicine, Antalya, Turkey (Türkiye)
- Istanbul University Istanbul Faculty of Medicine, Istanbul, Turkey (Türkiye)
- Istanbul University Cerrahpasa Faculty of Medicine, Istanbul, Turkey (Türkiye)
Collaborators
Data Management 365 · Atlant Clinical LLC · R-Pharm JSC · Unimed Laboratories · Exacte Labs LLC · Key Stat LLC · TRPharm İlaç Sanayi Ticaret Anonim Şirketi and ASCOT SCIENCE Education and Consulting Ltd. · Ascot Eğitim ve Danışmanlık LTD. ŞTİ.
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05092776 on ClinicalTrials.govOther trials for Familial Mediterranean fever
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNCT07212764Mobile App-Based Infection Monitoring in Familial Mediterranean FeverIstanbul University
- ENROLLING BY INVITATIONNANCT07013045Comparing Structured Neuromuscular Exercise and Exergaming Program in Adolescents With Familial Mediterranean FeverIstanbul University - Cerrahpasa
- RECRUITINGNANCT07129538Outcomes of Inspiratory Muscle Training in FMF AdolescentsCairo University
- RECRUITINGNANCT07130318Mediterranean Diet in Familial Mediterranean Fever: Is Fatty Liver Affected by Addition of Aerobic ExerciseCairo University
- RECRUITINGNANCT07130305is There an Effect of Adding Body Vibration to Intake of Vitamin D on Some Outcomes of Familial Mediterranean FeverCairo University
- ACTIVE NOT RECRUITINGNCT07128225Health-related Quality of Life, Electrocardiographic and Holter Findings in Children With Familial Mediterranean FeverSohag University
- RECRUITINGNCT06338891Can Gluten/Wheat or Other Foods be Responsible for FMF AttacksUniversity of Palermo
- ACTIVE NOT RECRUITINGNCT06257342Physical Abilities of Teenagers With Familial Mediterranean FeverVéronique Hentgen